A company developing a tiny, implantable drug pump to ease the burden of lifelong eye injections for patients with age-related macular degeneration, Replenish, Inc., has secured $100K. The funding comes as its MicroPump, designed for the $7 billion retinal therapeutic market, continues clinical investigation.
Replenish's MicroPump is the world's smallest refillable drug pump, intended to be implanted under the eye's skin. Once in place, physicians can wirelessly program and recharge it, refilling it every six months to deliver sight-saving biotech protein therapies that would otherwise require monthly syringe administrations.
